Starling Oncology, Inc. Proceeds from Sale of Productive Assets
Starling Oncology, Inc. (STLN) reported Proceeds from Sale of Productive Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2026-08-06
- Starling Oncology, Inc. proceeds from sale of productive assets for the quarter ending 2026-06-30 was $0.00.
- Starling Oncology, Inc. proceeds from sale of productive assets for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Starling Oncology, Inc. proceeds from sale of productive assets for the quarter ending 2025-12-31 was $0.00.
- Starling Oncology, Inc. proceeds from sale of productive assets for the quarter ending 2025-09-30 was $0.00.
- Starling Oncology, Inc. proceeds from sale of productive assets for fiscal 2025 was $126.00K.
- Starling Oncology, Inc. proceeds from sale of productive assets for fiscal 2024 was $0.00.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $126.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $126.00K 10-Q · filed 2025-11-13 | $126.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $126.00K 10-Q · filed 2026-08-06 | $126.00K derived: sum of 3 quarters · filed 2026-08-06 | $126.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $126.00K 10-Q · filed 2026-05-07 | $126.00K derived: sum of 2 quarters · filed 2026-05-07 | $126.00K derived: sum of 3 quarters · filed 2026-05-07 | $126.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 |